Edgar Lomax Company’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.3M | Sell |
49,038
-48,957
| -50% | -$17.5M | 1.23% | 37 |
|
|
2025
Q4 | $32.1M | Sell |
97,995
-2,315
| -2% | -$734K | 2.44% | 15 |
|
|
2025
Q3 | $28.3M | Sell |
100,310
-29,960
| -23% | -$8.69M | 2.22% | 17 |
|
|
2025
Q2 | $36.4M | Sell |
130,270
-2,115
| -2% | -$599K | 2.3% | 17 |
|
|
2025
Q1 | $41.2M | Sell |
132,385
-9,305
| -7% | -$2.75M | 2.58% | 15 |
|
|
2024
Q4 | $36.9M | Sell |
141,690
-2,775
| -2% | -$823K | 2.38% | 17 |
|
|
2024
Q3 | $46.5M | Sell |
144,465
-2,250
| -2% | -$736K | 2.84% | 10 |
|
|
2024
Q2 | $45.8M | Sell |
146,715
-1,885
| -1% | -$554K | 2.97% | 9 |
|
|
2024
Q1 | $42.2M | Sell |
148,600
-77,411
| -34% | -$22.7M | 2.61% | 12 |
|
|
2023
Q4 | $65.1M | Sell |
226,011
-9,375
| -4% | -$2.55M | 4.26% | 6 |
|
|
2023
Q3 | $63.3M | Sell |
235,386
-8,605
| -4% | -$2.15M | 4.31% | 4 |
|
|
2023
Q2 | $54.2M | Sell |
243,991
-3,384
| -1% | -$785K | 3.57% | 8 |
|
|
2023
Q1 | $59.8M | Buy |
247,375
+29,435
| +14% | +$7.23M | 3.85% | 8 |
|
|
2022
Q4 | $57.2M | Sell |
217,940
-1,190
| -0.5% | -$319K | 3.47% | 10 |
|
|
2022
Q3 | $49.4M | Sell |
219,130
-2,335
| -1% | -$566K | 3.41% | 10 |
|
|
2022
Q2 | $53.9M | Buy |
221,465
+5,920
| +3% | +$1.45M | 3.37% | 10 |
|
|
2022
Q1 | $52.1M | Buy |
215,545
+75,885
| +54% | +$17.4M | 3.06% | 12 |
|
|
2021
Q4 | $31.4M | Sell |
139,660
-1,260
| -0.9% | -$266K | 1.88% | 23 |
|
|
2021
Q3 | $30M | Sell |
140,920
-1,375
| -1% | -$316K | 1.92% | 23 |
|
|
2021
Q2 | $34.7M | Sell |
142,295
-6,875
| -5% | -$1.69M | 2.15% | 19 |
|
|
2021
Q1 | $37.1M | Buy |
+149,170
| New | +$35.6M | 2.31% | 18 |
|
|
2019
Q1 | – | Sell |
-81,778
| Closed | -$15.9M | – | 64 |
|
|
2018
Q4 | $15.9M | Sell |
81,778
-1,500
| -2% | -$293K | 1.21% | 27 |
|
|
2018
Q3 | $17.3M | Sell |
83,278
-2,900
| -3% | -$572K | 1.16% | 31 |
|
|
2018
Q2 | $15.9M | Buy |
86,178
+700
| +0.8% | +$124K | 1.12% | 29 |
|
|
2018
Q1 | $14.6M | Buy |
85,478
+27,625
| +48% | +$5.07M | 1.05% | 34 |
|
|
2017
Q4 | $10.1M | Sell |
57,853
-1,700
| -3% | -$301K | 0.69% | 42 |
|
|
2017
Q3 | $11.1M | Sell |
59,553
-4,979
| -8% | -$882K | 0.78% | 41 |
|
|
2017
Q2 | $11.1M | Sell |
64,532
-1,775
| -3% | -$289K | 0.76% | 41 |
|
|
2017
Q1 | $10.9M | Sell |
66,307
-71,812
| -52% | -$11.9M | 0.73% | 41 |
|
|
2016
Q4 | $20.2M | Sell |
138,119
-12,689
| -8% | -$1.91M | 1.29% | 29 |
|
|
2016
Q3 | $25.2M | Hold |
150,808
| – | – | 1.56% | 23 |
|
|
2016
Q2 | $22.9M | Buy |
150,808
+7,258
| +5% | +$1.13M | 1.44% | 26 |
|
|
2016
Q1 | $21.5M | Buy |
143,550
+112,350
| +360% | +$16.7M | 1.48% | 23 |
|
|
2015
Q4 | $5.07M | Buy |
+31,200
| New | +$4.9M | 0.37% | 51 |
|
|
2015
Q1 | – | Sell |
-1,775
| Closed | -$283K | – | 60 |
|
|
2014
Q4 | $283K | Sell |
1,775
-39,450
| -96% | -$6.15M | 0.02% | 68 |
|
|
2014
Q3 | $5.79M | Buy |
41,225
+1,000
| +2% | +$131K | 0.39% | 51 |
|
|
2014
Q2 | $4.76M | Buy |
40,225
+200
| +0.5% | +$23.2K | 0.34% | 52 |
|
|
2014
Q1 | $4.94M | Sell |
40,025
-24,050
| -38% | -$2.92M | 0.36% | 51 |
|
|
2013
Q4 | $7.31M | Sell |
64,075
-33,300
| -34% | -$3.79M | 0.55% | 42 |
|
|
2013
Q3 | $10.9M | Sell |
97,375
-8,750
| -8% | -$949K | 0.89% | 43 |
|
|
2013
Q2 | $10.5M | Buy |
+106,125
| New | +$11M | 0.81% | 44 |
|
Other funds holding AMGN
VCM
VPM
Edgar Lomax Company's AMGN Position: Q1 2026 in Review
Edgar Lomax Company reduced its Amgen (AMGN) stake by 50% in Q1 2026, selling an estimated $17.5M and leaving 49,038 shares worth $17.3M. The position accounts for 1.23% of the portfolio, ranked #37.
Edgar Lomax Company first reported a position in AMGN in Q2 2013 and has held it in 41 quarters since. The position peaked at $65.1M in Q4 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Edgar Lomax Company held 49,038 shares of Amgen worth $17.3M as of Q1 2026.
- Edgar Lomax Company sold 48,957 Amgen shares in Q1 2026, an estimated $17.5M.
- Amgen made up 1.23% of Edgar Lomax Company's portfolio in Q1 2026, its #37 holding.
- Edgar Lomax Company first reported a position in Amgen in Q2 2013 and has held it in 41 quarters since.
- Edgar Lomax Company's Amgen position peaked at $65.1M in Q4 2023.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Edgar Lomax Company's 13F filing for Q1 2026, filed 12 May 2026.